| 1 |
34663758 | Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer. | 2022 May 1 |
1 |
| 2 |
31771279 | Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts. | 2019 Nov 24 |
1 |
| 3 |
30023463 | Combination of BEZ235 and Metformin Has Synergistic Effect on Cell Viability in Colorectal Cancer Cells. | 2018 Jun |
1 |
| 4 |
23475782 | Coexistent mutations of KRAS and PIK3CA affect the efficacy of NVP-BEZ235, a dual PI3K/MTOR inhibitor, in regulating the PI3K/MTOR pathway in colorectal cancer. | 2013 Aug 15 |
5 |
| 5 |
22662154 | Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas. | 2012 |
1 |
| 6 |
22091388 | Signatures of drug sensitivity in nonsmall cell lung cancer. | 2011 |
1 |